Napoleon Waszkiewicz

Napoleon Waszkiewicz serves as a Professor in the Department of Psychiatry at the Faculty of Medicine with the Division of Dentistry and Division of Medical Education, Medical University of Bialystok, Poland, maintaining active research with over 375 publications documented in institutional repositories. His work bridges clinical psychiatry and biological mechanisms, emphasizing biomarker discovery across mental health conditions.

Research interests center on psychiatric disorders with strong emphasis on addictions, autism spectrum disorder, depression, and inflammatory pathways. He investigates environmental interactions including seasonality effects, microplastic exposure from tobacco products, and gut-brain axis dynamics using metabolomics and biomarker analysis. Current projects explore neurodevelopmental impacts of omega-3 fatty acids, probiotic interventions for depression, and diagnostic criteria for behavioral addictions like gaming disorder.

Analysis of his 2025 publications reveals thematic clustering around autism-related research (12 articles), depression-inflammation links (7 articles), and novel environmental risk factors (4 articles), demonstrating consistent focus on translational psychiatry through biomarker validation and mechanistic reviews. Methodologically, he favors metabolomics, narrative/systematic reviews, and clinical trial designs.

Scientific awards: No specific honors, fellowships, or medals are documented in the provided profile information.

Thesis supervision is indicated through the 'Promoted theses' section of his profile, though individual student names and grant funding details remain unspecified. Collaborative patterns show extensive co-authorship across Polish and international institutions, particularly in multi-center clinical trials and review articles spanning psychiatry, cardiology, and public health domains.

Laboratory infrastructure and dedicated research teams are not explicitly described in the available text, though his metabolomics studies suggest access to biochemical analysis facilities. Current projects imply ongoing work in autism biomarker validation and microplastic toxicity assessment.